Skip to main navigation
Skip to search
Skip to main content
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Search by expertise, name or affiliation
Prot #CD-RI-CAT-354-1066: A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults with Idiopathic Pulmonary Fibrosis
Medicine, Pulmonary Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
3/28/14
→
3/28/17
Funding
PPD Development
(Prot #CD-RI-CAT-354-1066)
MedImmune, LLC
(Prot #CD-RI-CAT-354-1066)
View all
View less